Patented encapsulation innovation - 3-layer protection for maximum stability and controlled release of Bacillus subtilis MM40® (DSM 21097; Budapest Treaty DSM 33619; EU Trademark No. 018279328), even under extreme climatic conditions.
Classical probiotics require an unbroken cold chain and lose the majority of their viability under real-world storage conditions. Even naturally stable spore-formers benefit from additional protection to maximize their efficacy.
Conventional probiotics (Lactobacillus, Bifidobacterium) require continuous refrigeration from manufacturer to consumer. Any interruption drastically reduces viable cell counts.
In target markets such as the Middle East, Africa and Southeast Asia, temperatures can render standard formulations ineffective within days of storage.
Even robust formulations can be compromised by the low pH of the stomach. Controlled release in the intestine is essential for targeted delivery.
Spores are inherently stable - yet additional technological protection maximizes survival rates and enables extended shelf life under all conditions.
MCT Technology combines three complementary protective layers into a unique encapsulation system that unifies stability, storage and controlled release in a single step.
The endospore of B. subtilis MM40® provides inherent resistance to heat, UV radiation, gastric acid and mechanical stress as the first protective layer. This natural resilience forms the foundation of the encapsulation system.
Medium-chain triglycerides (MCT) enclose the spore as the second protective layer. The MCT oil acts as a hydrophobic barrier against moisture and oxidative stress while simultaneously serving as a carrier for the outer sustained-release matrix.
The patented silicon-based sustained-release layer forms the outer encapsulation. It enables controlled, delayed release of the spore in the intestinal environment while providing additional protection against extreme storage conditions.
EU Patent EP3964195 covers the combination of Bacillus subtilis with silicon-based encapsulation, securing Magnat Vital a differentiated market position in the field of probiotic formulation.
MCT encapsulation solves central challenges in probiotic distribution and opens new market opportunities.
Shelf life of over 2 years at room temperature. No cold chain required - from production through to the end consumer.
Formulated for desert climates and tropical conditions. The 3-layer encapsulation protects even under sustained high temperatures.
The silicon sustained-release matrix enables targeted release of spores in the intestinal environment - precisely where they are needed.
Suitable for capsules, powders, sachets, functional foods and cosmetic formulations - maximum flexibility for partners.
Elimination of the cold chain reduces transport costs, carbon footprint and logistical complexity across the entire supply chain.
Reduced storage costs and simplified distribution enable cost-effective market access including in emerging economies.
MCT encapsulation technology is compatible with a broad range of end products and formulation targets.
Hard and soft capsules for dietary supplements and pharmaceutical applications.
Portioned powder blends for direct consumption or mixing into beverages.
Integration as an ingredient in functional foods, beverages and food products.
Formulation for dermatological and cosmetic products based on surfactin properties.
Leverage our patented encapsulation technology as the foundation for your own products - whether as raw material, white-label solution or within a strategic partnership.
